
Featured
July 4, 202615 min read
Q-RETIX.AI: Unlocking the "Undruggable" AIM2 Inflammasome
How Structural AI Bypassed the Electrostatic Charge Trap to Reignite a Dormant Therapeutic Target.
Read Article
Discover the latest insights in AI-powered drug discovery, structural biology, and precision medicine.

How Structural AI Bypassed the Electrostatic Charge Trap to Reignite a Dormant Therapeutic Target.

Why dynamic thermodynamic ensembles are the future of target identification and cryptic pocket discovery.

Exploring how allosteric molecular wedges are reshaping autoimmune drug design and inflammasome inhibition.

Mapping the multi-billion dollar market opportunity in SLE, psoriasis, and neurodegenerative disease.